Navigation Links
Free Dog Heart Checks at McAllister Park

SAN ANTONIO, Sept. 11 /PRNewswire/ -- The Mobile Dog Heart Health Tour is heading south to San Antonio, Texas, for an afternoon of free heart health examinations in San Antonio's McAllister Dog Park. From 3 p.m. to 8 p.m. on September 17, certified veterinary cardiologists will be performing on site heart screenings in a soundproof medical unit, as well as educating owners about canine heart disease.

(Photo: )

(Photo: )

Since early 2009, veterinarians on the Mobile Dog Heart Health Tour have checked the hearts of more than 5,000 dogs around the country and found a previously undetected heart murmur in approximately 20 percent of them. In addition to providing free heart health screenings, veterinarians help to educate dog owners about heart disease – a common ailment that is almost as prevalent in dogs as it is in humans.

About 11 percent of the nearly 75 million dogs in the United States have heart disease(1), and that figure increases to as many as 60 percent among aged dogs and certain predisposed breeds(2). Yet, a national survey shows that more than half of dog owners are unaware that their dog may be at risk of heart failure.

"Early diagnosis and treatment of heart disease can significantly prolong and improve the quality of a dog's life," says Dr. Katie Meier a veterinarian with the Mobile Dog Heart Health Tour. "We look forward to educating local dog owners about heart disease in dogs and the treatment options. By emphasizing the importance of annual veterinary examinations and early diagnosis of heart disease, we hope to help more dogs live longer and better lives."

Veterinary specialists will perform the free dog heart screenings from 3:00 p.m. until 8:00 p.m at McAllister Park, located at 13102 Jones Maltsberger Road. The certified veterinary cardiologists use a stethoscope to listen for heart murmurs and other irregular sounds as well as generally assess whether or not the dogs show any signs of heart disease. Veterinarians will also educate dog owners about the most common symptoms of heart disease: reduced willingness to walk or exercise, difficulty breathing, coughing, loss of appetite and weight loss. Dog owners can learn more at

Mobile Dog Heart Health Tour stop at McAllister ParkWhen:

Friday, September 17, 2010, from 3:00 p.m. – 8:00 p.m.Where:

McAllister Park, San Antonio, Texas
13102 Jones Maltsberger RoadWhy:

To educate dog owners about canine heart diseaseWho:

Veterinary cardiologists will perform free dog heart screeningsAbout Congestive Heart Failure in Dogs

The Mobile Dog Heart Health Tour is designed to educate people about congestive heart failure (CHF) in dogs.

While there is no cure for CHF, clinical study results have shown that dogs with the condition live nearly twice as long and enjoy a higher quality of life when diagnosed and treated during the early stages of heart failure.

About Boehringer Ingelheim Vetmedica, Inc.

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 142 affiliates in 50 countries and more than 41,500 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.

In 2009, Boehringer Ingelheim posted net sales of US $17.7 billion (12.7 billion euro) while spending 21% of net sales in its largest business segment, Prescription Medicines, on research and development. For more information, please visit


(1.) Buchanan JW. Causes and prevalence of cardiovascular disease. Curr Vet Ther. 1992;XI:646.

(2.) Rush JE. Chronic Valvular Heart Disease in Dogs. Proceedings of the 26th Annual Waltham Diets/OSU Symposium: Small Animal Cardiology, 2002.

Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Pharmacists May Help Patients Prevent and Detect Heart Disease
2. Biohearts MyoCell Recognized as one of the Breakthrough Developments of 2010
3. Cardioxyl Pharmaceuticals Initiates Dose-Defining Phase IIa Study of Its Lead Candidate, CXL-1020, in Heart Failure Patients
4. People at Intermediate Risk of Heart Disease With Elevated hsCRP Benefit From Statin Therapy Even if Cholesterol Levels are Normal
5. Southwest Hospitals MRI Centers Commitment to State-of-the-Art Technology at the Heart of Nearly 20-Year Relationship with MedInformatix RIS
6. American Heart Association Comment: Advisory Committee Recommends that U.S. Food and Drug Administration Keep Rosiglitazone (Avandia) on the Market, Continue Clinical Trial of Safety and Efficacy
7. HeartSine Technologies Recognized as an Index 30 Company at New York-New Belfast Conference
8. Heart Device Manufacturer in Minnesota and Hospitals in Ohio & Kentucky to Pay Nearly $4 Million to Resolve Fraud Allegations
9. Health Network Laboratories (HNL) Enters Into License Agreement With Hunter Laboratories to Provide HunterHeart Cardiovascular Disease Management Program.
10. Abbotts Investigational MitraClip(R) System Demonstrates Strong Safety Results and Improved Clinical Outcomes for Common Causes of Leaky Heart Valves
11. HeartSine Technologies Supports Living for Zachary Benefit Golf Tournament
Post Your Comments:
(Date:11/30/2015)... Calif. , Nov. 30, 2015 /PRNewswire/ ... the norm in U.S. medical imaging is ... increasingly popular accountable care payer-provider contracts are ... and, in their wake, alter provider-vendor relationships. ... payments will push forward new purchasing frameworks ...
(Date:11/30/2015)... JERUSALEM , Nov. 30, 2015 Oramed ... company focused on the development of oral drug delivery ... investment agreements valued at up to $50,000,000 with Hefei Tianhui Incubator of ... Oramed,s oral insulin capsule, ORMD-0801, in China ... Macau . The agreements were signed ...
(Date:11/30/2015)... N.H. , Nov. 30, 2015 ... that it will feature its latest solutions for ... early identification of cancer at the Radiological Society ... Chicago from November 29 ... recent product advances including iReveal®, an automated breast ...
Breaking Medicine Technology:
(Date:11/30/2015)... ... November 30, 2015 , ... ... announce the speakers for “Value-Based Payer-Provider Partnerships: Three Case Studies,” an upcoming ... value-based care arrangements: Essentia Health and UCare, MissionPoint Health Partners, and Intel ...
(Date:11/30/2015)... EMIGSVILLE, PA (PRWEB) , ... November 30, 2015 ... ... (CCMS) software provider, has verified that their Vasont Universal Integrator (VUI) extension unites ... handle creating, editing, and managing content as a continuous process with the latest ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... is one of a select few plastic surgeons in the New York City ... , SculpSure™ is the world’s first heat-induced laser treatment for fat loss in ...
(Date:11/30/2015)... ... November 30, 2015 , ... TransPack Volume 6 features 30 customizable transitions created ... web-styled transitions to wipes with blur & drop shadow options. Utilize the controls ... from one clip to the next with TransPack's easily customizable styles. , ...
(Date:11/30/2015)... , ... November 30, 2015 ... ... Inc. are pleased to announce their strategic partnership at the Radiological Society ... Transcription Service, Inc., and Winscribe, global providers of cutting-edge dictation and speech-enabled ...
Breaking Medicine News(10 mins):